Home » Topics » BioWorld Science

BioWorld Science
RSS

Prescient Therapeutics reports interim durability data on PTX-200 in breast cancer

Dec. 11, 2018

WDR5/MLL1 interaction inhibitors identified at the University of Michigan

Dec. 11, 2018

LegoChem Biosciences patents E-NPP 2 inhibitors

Dec. 11, 2018

Oppilan Pharma presents sphingosine 1-phosphate receptor 1 agonists

Dec. 11, 2018

Phase I study of silmitasertib shows promise in patients with cholangiocarcinoma

Dec. 11, 2018

Phase II study of serlopitant demonstrates reduction of pruritus associated with psoriasis

Dec. 11, 2018

Phase II study of zilucoplan in gMG meets primary and key secondary endpoints

Dec. 11, 2018

Vanda presents promising data from pivotal study of tasimelteon in Smith-Magenis syndrome

Dec. 11, 2018

In MDS and AML, many bad seeds

Dec. 11, 2018

Metastasis of triple-negative breast cancer is controlled by PEA15 phosphorylation

Dec. 11, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...